196 related articles for article (PubMed ID: 17218796)
1. Methylphenidate and its ethanol transesterification metabolite ethylphenidate: brain disposition, monoamine transporters and motor activity.
Williard RL; Middaugh LD; Zhu HJ; Patrick KS
Behav Pharmacol; 2007 Feb; 18(1):39-51. PubMed ID: 17218796
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and pharmacology of ethylphenidate enantiomers: the human transesterification metabolite of methylphenidate and ethanol.
Patrick KS; Williard RL; VanWert AL; Dowd JJ; Oatis JE; Middaugh LD
J Med Chem; 2005 Apr; 48(8):2876-81. PubMed ID: 15828826
[TBL] [Abstract][Full Text] [Related]
3. Ethylphenidate formation in human subjects after the administration of a single dose of methylphenidate and ethanol.
Markowitz JS; DeVane CL; Boulton DW; Nahas Z; Risch SC; Diamond F; Patrick KS
Drug Metab Dispos; 2000 Jun; 28(6):620-4. PubMed ID: 10820132
[TBL] [Abstract][Full Text] [Related]
4. Influence of ethanol and gender on methylphenidate pharmacokinetics and pharmacodynamics.
Patrick KS; Straughn AB; Minhinnett RR; Yeatts SD; Herrin AE; DeVane CL; Malcolm R; Janis GC; Markowitz JS
Clin Pharmacol Ther; 2007 Mar; 81(3):346-53. PubMed ID: 17339864
[TBL] [Abstract][Full Text] [Related]
5. Transdermal and oral dl-methylphenidate-ethanol interactions in C57BL/6J mice: transesterification to ethylphenidate and elevation of d-methylphenidate concentrations.
Bell GH; Novak AJ; Griffin WC; Patrick KS
J Pharm Sci; 2011 Jul; 100(7):2966-78. PubMed ID: 21240977
[TBL] [Abstract][Full Text] [Related]
6. Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.
Froimowitz M; Gu Y; Dakin LA; Nagafuji PM; Kelley CJ; Parrish D; Deschamps JR; Janowsky A
J Med Chem; 2007 Jan; 50(2):219-32. PubMed ID: 17228864
[TBL] [Abstract][Full Text] [Related]
7. Ethylphenidate as a selective dopaminergic agonist and methylphenidate-ethanol transesterification biomarker.
Patrick KS; Corbin TR; Murphy CE
J Pharm Sci; 2014 Dec; 103(12):3834-3842. PubMed ID: 25303048
[TBL] [Abstract][Full Text] [Related]
8. Isopropylphenidate: an ester homolog of methylphenidate with sustained and selective dopaminergic activity and reduced drug interaction liability.
Markowitz JS; Zhu HJ; Patrick KS
J Child Adolesc Psychopharmacol; 2013 Dec; 23(10):648-54. PubMed ID: 24261661
[TBL] [Abstract][Full Text] [Related]
9. Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.
Carroll FI; Runyon SP; Abraham P; Navarro H; Kuhar MJ; Pollard GT; Howard JL
J Med Chem; 2004 Dec; 47(25):6401-9. PubMed ID: 15566309
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of the enantiomers of threo-methylphenidate.
Patrick KS; Caldwell RW; Ferris RM; Breese GR
J Pharmacol Exp Ther; 1987 Apr; 241(1):152-8. PubMed ID: 3572779
[TBL] [Abstract][Full Text] [Related]
11. Differential pharmacokinetics and pharmacodynamics of methylphenidate enantiomers: does chirality matter?
Markowitz JS; Patrick KS
J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S54-61. PubMed ID: 18480678
[TBL] [Abstract][Full Text] [Related]
12. Influence of ethanol on the pharmacokinetics of methylphenidate's metabolites ritalinic acid and ethylphenidate.
Koehm M; Kauert GF; Toennes SW
Arzneimittelforschung; 2010; 60(5):238-44. PubMed ID: 20533759
[TBL] [Abstract][Full Text] [Related]
13. Genetic aspects on the effects of ethanol and central stimulants on locomotor activity and brain dopamine metabolism in mice.
Liljequist S; Karcz-Kubicha M
Alcohol Alcohol Suppl; 1993; 2():457-61. PubMed ID: 7748339
[TBL] [Abstract][Full Text] [Related]
14. Asymmetric synthesis and pharmacology of methylphenidate and its para-substituted derivatives.
Thai DL; Sapko MT; Reiter CT; Bierer DE; Perel JM
J Med Chem; 1998 Feb; 41(4):591-601. PubMed ID: 9484508
[TBL] [Abstract][Full Text] [Related]
15. Effects of amphetamine isomers, methylphenidate and atomoxetine on synaptosomal and synaptic vesicle accumulation and release of dopamine and noradrenaline in vitro in the rat brain.
Easton N; Steward C; Marshall F; Fone K; Marsden C
Neuropharmacology; 2007 Feb; 52(2):405-14. PubMed ID: 17020775
[TBL] [Abstract][Full Text] [Related]
16. Analytical characterization and pharmacological evaluation of the new psychoactive substance 4-fluoromethylphenidate (4F-MPH) and differentiation between the (±)-threo and (±)-erythro diastereomers.
McLaughlin G; Morris N; Kavanagh PV; Power JD; Dowling G; Twamley B; O'Brien J; Hessman G; Murphy B; Walther D; Partilla JS; Baumann MH; Brandt SD
Drug Test Anal; 2017 Mar; 9(3):347-357. PubMed ID: 28103426
[TBL] [Abstract][Full Text] [Related]
17. L- and D-threo ethylphenidate concentrations, pharmacokinetics, and pharmacodynamics in horses.
Knych HK; McKemie DS; Seminoff K; Hartmann P; Hovda L; Benson D
Drug Test Anal; 2018 Oct; 10(10):1508-1517. PubMed ID: 29786965
[TBL] [Abstract][Full Text] [Related]
18. Detection of the novel metabolite ethylphenidate after methylphenidate overdose with alcohol coingestion.
Markowitz JS; Logan BK; Diamond F; Patrick KS
J Clin Psychopharmacol; 1999 Aug; 19(4):362-6. PubMed ID: 10440465
[TBL] [Abstract][Full Text] [Related]
19. Involvement of central histaminergic systems in modafinil-induced but not methylphenidate-induced increases in locomotor activity in rats.
Ishizuka T; Murakami M; Yamatodani A
Eur J Pharmacol; 2008 Jan; 578(2-3):209-15. PubMed ID: 17920581
[TBL] [Abstract][Full Text] [Related]
20. Toxicokinetic assessment of methylphenidate (Ritalin) enantiomers in pregnant rats and rabbits.
Bakhtiar R; Tse FL
Biomed Chromatogr; 2004 Jun; 18(5):275-81. PubMed ID: 15236434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
